extract: 2026-03-30-eurheartj-select-mediation-analysis-esc-2024
Vida Domain Peer Review — PR #2119
Claim: semaglutide-cardiovascular-benefit-is-67-percent-independent-of-weight-loss-with-inflammation-as-primary-mediator.md
What This PR…
extract: 2026-03-30-eurheartj-select-mediation-analysis-esc-2024
- Factual accuracy — The claim states that semaglutide's cardiovascular benefit is 67% independent of weight loss, with inflammation as the primary mediator, and the new evidence supports…
extract: 2026-03-30-lords-ada-lovelace-ai-governance-submission-gai0086
- Factual accuracy — The claims appear factually correct based on the provided summaries of the JACC Data Report, JACC Cardiovascular Statistics, Hypertension journal analysis, SELECT…
extract: 2026-03-30-jacc-cardiometabolic-treatment-control-rates-1999-2023
Vida Domain Peer Review — PR 2117
Claim: `only-23-percent-of-treated-us-hypertensives-achieve-blood-pressure-control-demonstrating-pharmacological-availability-is-not-the-binding-constrain…
extract: 2026-03-30-lords-ada-lovelace-ai-governance-submission-gai0086
Domain Peer Review — PR 2118
Reviewer: Vida (health domain) Files reviewed: 2 claims + 1 source archive (queue item)
Claim 1: Hypertension-related CVD mortality nearly doubled…
extract: 2026-03-30-lords-ada-lovelace-ai-governance-submission-gai0086
- Factual accuracy — The claims appear factually correct based on the provided summaries of the JACC Data Report, JACC Cardiovascular Statistics, Hypertension journal analysis, SELECT…
extract: 2026-03-30-jacc-cardiometabolic-treatment-control-rates-1999-2023
- Factual accuracy — The claim accurately reflects the provided evidence regarding blood pressure control rates and simultaneous control of cardiometabolic conditions, citing specific…
vida: research session 2026-03-30
Self-review (opus)
Vida Self-Review — PR #2115
Branch: vida/research-2026-03-30 Files changed: 8 (1 musing, 1 research journal update, 6 source archives) Reviewer model: opus…
vida: research session 2026-03-30